The global foot orthotic insoles market size is expected to reach USD 4.50 billion by 2027. This is attributable to the rising geriatric population and the increasing incidence of diabetes that is driving the demand for advanced foot orthotic insoles globally. Fortune Business Insights, in its latest report, titled, “Foot Orthotic Insoles Market Size, Share COVID-19 Impact Analysis, By Type (Prefabricated and Customized), By Application (Medical, Sports Athletics, and Personal), By Material (Thermoplastics, Ethyl-vinyl Acetate (EVA), Foam, Composite Carbon Fibre, and Others), By Age Group (Pediatrics and Adults), By Distribution Channel (Hospital Pharmacies, Retail Stores, and Online Stores), and Regional Forecast, 2020-2027.”, observes that the market stood at USD 3.25 billion in 2019 and is likely to exhibit a CAGR of 6.1% between 2020 and 2027.
Suspension of Several Non-COVID-19 Healthcare Procedure to Impact Market Revenue
Due to cancellation or rescheduling of several outpatient appointments, the patient volume in orthotics and podiatry clinics has decreased significantly. This is owing to the growing shift towards treating COVID-19 patients on the advisory of the government agencies globally. This is likely to affect the revenue generation of the orthotic department. However, the growing adoption of digital technologies by the orthotic clinics is likely to favor the market growth in the forthcoming years.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Increasing Incidence of Diabetes Globally to Accelerate Growth
According to the National Center for Biotechnology Information, the prevalence of diabetic foot ulcers is between 9.1 to 26.1 million every year globally. Furthermore, around 20% to 25% of the population with diabetes mellitus are likely to develop diabetic foot ulcers in a lifetime. Therefore, the growing incidence of diabetes is expected to propel the demand for advanced foot orthotic insoles.
Medical Segment to Hold Dominant Market Share
The medical segment, based on application, is expected to gain momentum backed by the growing number of clinical evidence proving the efficacy of foot orthotic insoles in reducing pain among the patients globally.
More Trending Topics from Fortune Business Insights: